Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Financial Instruments

v3.8.0.1
Note 11 - Financial Instruments
9 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
(
11
)     F
inancial Instruments
 
At
March 31, 2018
and
June 30, 2017,
$7.1
million and
$7.3
million, respectively, of cash equivalents were restricted and classified as a long-term asset. We did
not
hold any available-for-sale securities at
March 31, 2018
or
June 30, 2017.
 
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
 
We measure certain assets, including our cost and equity method investments, at fair value on a nonrecurring basis. These assets are recognized at fair value when they are deemed to be other-than-temporarily impaired. During the
nine
month period ended
March 31, 2018,
we did
not
record any other-than-temporary impairments on those assets required to be measured at fair value on a non-recurring basis.